They strongly endorsed moderate hypofractionation (20 or 26 treatments) but only conditionally endorsed SBRT because they didn't consider any data after 3/31/2017. I think SBRT will receive a strong endorsement by this time next year.
There is no reason any patient should have to suffer through and pay the expense of 40-44 primary IMRT treatments anymore. If you have an RO telling you you need 40-44 treatments, show him the new guidelines.